-
Bank Ranking
Banks Ratios
Cement Statistics
Cement Ranking
Cement Ratios
Monetary and Economic Statistics
Oil, Gas and Fuel
Macro Economy
Consumer Spending
Inflation
Exports & Imports
Food Prices
Non Food Prices
Construction Materials
Petrochem. Ranking
Petrochem. Ratios
Retail Rankings
Retail Ratios
Grocery Ranking
Grocery Ratios
Top Growth
Dividend History
Jamjoom Pharma Q4 2024: What are analysts predicting?
In this report, Argaam highlights the expected results of Jamjoom Pharmaceuticals Factory Co. in Q4 2024, as well as its key events, quarterly sales and profit, and performance indicators.
The company is projected to post a 22% year-on-year (YoY) jump in the fourth-quarter revenue to SAR 253.75 million.
Quarter Revenue Changes (M Riyal)
| Item | Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 (Average Estimate) |
|---|---|---|---|---|---|
| Sales | 207.86 | 385.46 | 345.74 | 327.58 | 253.75 |
| Change % | 5.60% | 28.12% | 15.86% | 11.95% | 22.08% |
| Income from Affiliate | 5.33 | 1.76 | 2.01 | 7.07 | NA |
| Change % | NA | NA | NA | NA | NA |
Quarter Net Income Changes (M Riyal)
| Item | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 (Average Estimate) |
|---|---|---|---|---|---|
| Net Income | 44.48 | 102.97 | 106.95 | 94.99 | 55.80 |
| Extraordinary income/expense | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Net Profit Before Unusual Items | 44.48 | 102.97 | 106.95 | 94.99 | - |
| EPS Before Unusual Items (Riyal/Share) | 0.64 | 1.47 | 1.53 | 1.36 | 0.80 |
Key events in Q4 2024
The company's key performance indicators remained steady, standing on par with the results of the first nine months of 2024 and projections for the remainder of the year.
Quarterly Profit and Revenue (M Riyal)
Average forecasts
The company is forecast to record a net profit of SAR 55.8 million in Q4 2024, a rise of 25.4% from SAR 44.5 million in Q4 2023, based on average estimates by five research houses.
Quarterly Actuals vs Estimates (M Riyal)
Average Estimate (M Riyal)
| Analyst | Million Riyals |
|---|---|
| United Securities Company | 69.00 |
| GIB Capital LLC | 57.00 |
| Osool and Bakheet Investment Co. | 55.21 |
| SNB Capital Company | 49.80 |
| Al Rajhi Capital Company | 48.00 |
| Average | 55.80 |
| Net Profit Before Unusual Items (2023 - Q4) | 44.48 |
| Change % | 25.44% |
Performance & profitability indicators
The following table shows the stock performance trailing 12 months (TTM) and year to date, as well as its P/E and earnings per share:
Stock Performance
| Item | The Company | TASI |
|---|---|---|
| YTD | 7.36 % | 2.80 % |
| Change(12M) | 17.72 % | 3.58 % |
| Previous Close | 165.00 | 12,439.48 |
| P/E adjusted (x) | 32.74 | 25.07 |
| EPS (TTM) before unusual items (SAR/Share) | 4.99 | - |
Valuation Data (Latest Share Price)
| P/E (TTM) | 32.74 |
| P/E Before Unusual Items (TTM) | 32.74 |
| P/BV | 7.92 |
| Dividend Yield | 2.17 % |
| Market Cap. (M) | 11,438.00 |
| Return on Average Assets | 19.87 % |
| Return on Average Equity | 24.90 % |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}